EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unrevealing role of TLRs/NLRP receptors in halting Alzheimer's neuroinflammation: Current progress and existing therapies

Shubham Upadhayay

International Immunopharmacology · 2026-03 · 173 · 116285

DOI: 10.1016/j.intimp.2026.116285 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Immunopharmacology, 2026-03. Verfasst von Shubham Upadhayay. Beteiligte Einrichtung: Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Kishangarh, Rajasthan 305817, India. Electronic ad…. Hauptthemen laut MEDLINE: Alzheimer Disease, Toll-Like Receptors, Neuroinflammatory Diseases, NLR Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 385 Literaturangaben. Gefördert von: Central University of Rajasthan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer's disease (AD) is a multifactorial condition caused by genetic, environmental, metabolic, and immunological factors. These pathological alterations trigger oxidative stress, excitotoxicity, and neuroinflammation, leading to the degeneration of cholinergic neurons in the brain. Several studies have found that persistent neuroinflammation plays a key role in AD progression; still, no curative medicine is available to halt the disease progression. For this reason, exploring new target-based therapy is necessary for AD treatment. The current review aims to understand the inflammatory processes associated with the activation of toll-like receptors (TLRs) and Inflammasomes (NLRPs) in AD progression. Additionally, the impact of TLR and NLRP inhibitors on improving the condition of AD patients. As multiple studies have confirmed, TLR/NLRP activation stimulates the infiltration of inflammatory cytokines, which enhances AD severity. Similarly, various studies have shown that inhibition of the TLR/NLRP signaling axis reduces oxidative stress, inflammatory cytokines, and apoptosis, thereby demonstrating a neuroprotective effect. This review examines the roles of TLR and NLRP pathways in AD progression, focusing on preclinical and clinical evidence supporting the neuroprotective benefits of targeting these pathways in AD. This review extensively examined the molecular mechanisms of TLR/NLRP inhibitors, highlighting recent discoveries that could be used to initiate clinical trials in patients with Alzheimer's.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseToll-Like ReceptorsNeuroinflammatory DiseasesNLR ProteinsNeuroprotective AgentsHumansAnimalsInflammasomesSignal Transduction

Stichwörter der Autor:innen

Alzheimer’s DiseaseAstrocyteCytokinesInflammasomeMicrogliaNeuroinflammationTLR/NLRP

Substanzen

Toll-Like ReceptorsInflammasomesNLR ProteinsNeuroprotective Agents

Autor:innen und Institutionen

  • Department of Pharmacy, School of Chemical Sciences and Pharmacy, Central University of Rajasthan, Kishangarh, Rajasthan 305817, India. Electronic address: upadhayay.shubham11@gmail.com.

Förderung

  • Central University of Rajasthan

Zitieren

APA

Upadhayay, S. (2026). Unrevealing role of TLRs/NLRP receptors in halting Alzheimer's neuroinflammation: Current progress and existing therapies. International Immunopharmacology, 173, 116285. https://doi.org/10.1016/j.intimp.2026.116285

Vancouver

Upadhayay S. Unrevealing role of TLRs/NLRP receptors in halting Alzheimer's neuroinflammation: Current progress and existing therapies. International Immunopharmacology. 2026;173:116285. doi:10.1016/j.intimp.2026.116285

BibTeX
@article{Upadhayay2026,
  author = {Upadhayay, Shubham},
  title = {Unrevealing role of TLRs/NLRP receptors in halting Alzheimer's neuroinflammation: Current progress and existing therapies},
  journal = {International Immunopharmacology},
  year = {2026},
  volume = {173},
  pages = {116285},
  doi = {10.1016/j.intimp.2026.116285}
}
Kostenlos starten →